Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$90.44 Million ≈ $2.85 Million USD) by net assets (NT$3.18 Billion ≈ $100.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chunghwa Chemical Synthesis & Biotech Co stock valuation for the company's overall valuation and market capitalisation.
Chunghwa Chemical Synthesis & Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore Chunghwa Chemical Synthesis & Biotech Co cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dong Yang Pipe
KO:008970
|
-0.111x |
|
KKB Engineering Berhad
KLSE:9466
|
-0.035x |
|
Seoul Electronics & Telecom Co. Ltd
KQ:027040
|
-0.173x |
|
Ying Han Technology Co Ltd
TW:4562
|
0.009x |
|
Senkron Guvenlik ve Iletisim Sistemleri AS
IS:SNKRN
|
0.017x |
|
MSC Co. Ltd
KQ:009780
|
0.024x |
|
MEGA International Development Co Ltd
TWO:5529
|
0.360x |
|
Korea Computer & Systems Inc
KQ:115500
|
0.039x |
Annual Cash Flow Conversion Efficiency for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. View Chunghwa Chemical Synthesis & Biotech Co stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$3.09 Billion ≈ $97.27 Million |
NT$142.61 Million ≈ $4.49 Million |
0.046x | -66.84% |
| 2024-12-31 | NT$3.36 Billion ≈ $105.76 Million |
NT$467.65 Million ≈ $14.73 Million |
0.139x | +702.20% |
| 2023-12-31 | NT$3.35 Billion ≈ $105.55 Million |
NT$-77.50 Million ≈ $-2.44 Million |
-0.023x | -110.07% |
| 2022-12-31 | NT$3.19 Billion ≈ $100.60 Million |
NT$733.78 Million ≈ $23.12 Million |
0.230x | +203.46% |
| 2021-12-31 | NT$2.89 Billion ≈ $91.19 Million |
NT$219.18 Million ≈ $6.91 Million |
0.076x | +36.88% |
| 2020-12-31 | NT$2.50 Billion ≈ $78.72 Million |
NT$138.24 Million ≈ $4.36 Million |
0.055x | -58.42% |
| 2019-12-31 | NT$2.02 Billion ≈ $63.49 Million |
NT$268.13 Million ≈ $8.45 Million |
0.133x | +12.49% |
| 2018-12-31 | NT$1.98 Billion ≈ $62.50 Million |
NT$234.66 Million ≈ $7.39 Million |
0.118x | +35.20% |
| 2017-12-31 | NT$1.82 Billion ≈ $57.38 Million |
NT$159.34 Million ≈ $5.02 Million |
0.087x | -40.70% |
| 2016-12-31 | NT$1.77 Billion ≈ $55.80 Million |
NT$261.31 Million ≈ $8.23 Million |
0.148x | +245.00% |
| 2015-12-31 | NT$1.86 Billion ≈ $58.72 Million |
NT$79.70 Million ≈ $2.51 Million |
0.043x | +199.40% |
| 2014-12-31 | NT$1.62 Billion ≈ $50.91 Million |
NT$23.08 Million ≈ $727.18K |
0.014x | -83.17% |
| 2013-12-31 | NT$1.71 Billion ≈ $53.91 Million |
NT$145.24 Million ≈ $4.58 Million |
0.085x | -47.02% |
| 2012-12-31 | NT$1.68 Billion ≈ $52.79 Million |
NT$268.46 Million ≈ $8.46 Million |
0.160x | +85.46% |
| 2011-12-31 | NT$1.68 Billion ≈ $52.82 Million |
NT$144.84 Million ≈ $4.56 Million |
0.086x | -47.25% |
| 2010-12-31 | NT$1.68 Billion ≈ $53.01 Million |
NT$275.61 Million ≈ $8.68 Million |
0.164x | -57.67% |
| 2009-12-31 | NT$1.19 Billion ≈ $37.63 Million |
NT$462.07 Million ≈ $14.56 Million |
0.387x | +329.84% |
| 2008-12-31 | NT$837.53 Million ≈ $26.39 Million |
NT$75.39 Million ≈ $2.38 Million |
0.090x | -- |
About Chunghwa Chemical Synthesis & Biotech Co Ltd
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DM… Read more